Cardiology

  • Preoperative VTEs occurred in 10% of cancer patients

    on March 27th, 2017
    AT SSO 2017 SEATTLE (FRONTLINE MEDICAL NEWS)– Venous thromboembolism (VTE) is common in cancer, but 10% of asymptomatic patients undergoing major oncologic surgery have a preoperative VTE, according to findings presented at the annual Society of Surgical Oncology Cancer Symposium. The incidence of[...]
  • Digoxin definitively dissed for AF

    on March 24th, 2017
    AT ACC 17 WASHINGTON (FRONTLINE MEDICAL NEWS) – In what could prove to be the final word in the clinical controversy over the safety of prescribing digoxin in patients with atrial fibrillation, a secondary analysis of the roughly 18,000-patient ARISTOTLE trial has come down emphatically on the sid[...]
  • Study boosts surgical left atrial appendage occlusion

    on March 24th, 2017
    At ACC 17 WASHINGTON (FRONTLINE MEDICAL NEWS) – Surgical left atrial appendage occlusion in older patients with atrial fibrillation already undergoing cardiac surgery was associated with a 38% reduction in thromboembolism and a 15% lower risk of all-cause mortality during the subsequent year in a [...]
  • Dabigatran crushes warfarin for AF ablation

    on March 23rd, 2017
    At ACC 17 Washington (FRONTLINE MEDICAL NEWS) – Uninterrupted dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation proved far superior to uninterrupted warfarin – the current standard – in the randomized multicenter RE-CIRCUIT trial, Hu[...]
  • Levosimendan does not improve 30-day mortality following cardiac surgery

    on March 21st, 2017
    FROM ESICM CONGRESS 2017 Adding a low dose of levosimendan to the standard care for patients on perioperative hemodynamic support does not improve outcomes to any significant extent, according to the findings of a new study presented at the annual congress of the European Society of Intensive Care M[...]
  • Intensive ventilation precedes lesser pulmonary complications

    on March 21st, 2017
    FROM ISICEM Addition of 10 cm H2O to positive end-expiratory volume (PEEP) during mechanical ventilation was followed by significantly lessened pulmonary complications in hospitalized patients who developed hypoxemia after cardiac surgery, participating in a single-center, randomized trial. This “[...]
  • Get With the Guidelines propels stroke thrombolytic therapy

    on March 20th, 2017
    EXPERT ANALYSIS FROM THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Thrombolytic therapy for U.S. patients experiencing an acute ischemic stroke is no longer the poster child for proven, but neglected, therapies. Long bemoaned since its introduction in the mid-1990s as an e[...]
  • Older TAVR implant devices significantly less effective than newer ones in bicuspid AS patients

    on March 20th, 2017
    From ACC 17 Using transcatheter aortic valve replacement (TAVR) to treat bicuspid aortic valve stenosis (AS) can be significantly less effective than using TAVR to treat tricuspid AS, according to the findings of a new study presented at the annual meeting of the American College of Cardiology and p[...]
  • VIDEO: Subclinical leaflet thrombosis frequent after TAVR, SAVR

    on March 20th, 2017
    AT ACC 17 WASHINGTON (FRONTLINE MEDICAL NEWS) – Subclinical leaflet thrombosis, as evidenced by reduced leaflet motion and corresponding hypoattenuating lesions on high-resolution CT, occurs frequently in bioprosthetic aortic valves implanted either by the transcatheter route or surgically, accord[...]
  • BNP flags high atrial fibrillation prevalence in ESUS stroke

    on March 20th, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Following an embolic stroke of undetermined source, a patient’s serum level of brain natriuretic peptide may identify patients at high risk of having covert atrial fibrillation that warrants assessment by prolonged arrhyth[...]
  • Evolocumab strikes gold in FOURIER trial

    on March 20th, 2017
    AT ACC 17 WASHINGTON (FRONTLINE MEDICAL NEWS) – The PCSK9 inhibitor evolocumab reduced the incidence of the composite endpoint of cardiovascular death, MI, or stroke by an additional 20% in patients with established cardiovascular disease who were already on background maximum-tolerated statin the[...]
  • Cardiovascular disease most common cause of death in CRC survivors

    on March 20th, 2017
    AT SSO 2017 SEATTLE (FRONTLINE MEDICAL NEWS) – Improvements in diagnosis and treatment have lengthened the survival time of patients with colorectal cancer, but the majority of deaths from CRC occur within the first 5 years. According to new findings presented at the annual Society of Surgical Onc[...]
  • Evolocumab doesn’t make patients dumb

    on March 20th, 2017
    AT ACC 17 WASHINGTON (FRONTLINE MEDICAL NEWS) – Concerns about possible adverse cognitive effects from the new lipid-lowering drug evolocumab and from aggressive lowering of LDL cholesterol were largely put to rest with results from a nearly 2,000-patient study showing that a median 20 months of t[...]
Back to top